Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Progyny Q4 2023 GAAP EPS $0.13 Beats $0.10 Estimate, Sales $269.94M Miss $273.66M Estimate

Author: Benzinga Newsdesk | February 27, 2024 05:14pm
Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.10 by 30 percent. The company reported quarterly sales of $269.94 million which missed the analyst consensus estimate of $273.66 million by 1.36 percent. This is a 25.95 percent increase over sales of $214.32 million the same period last year.

Posted In: PGNY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist